fda approvals in nets, breast cancer, aml, a biosimilar, and more
Published 6 years ago • 167 plays • Length 8:51
Download video MP4
Download video MP3
Similar videos
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
8:21
fda approval of a biosimilar, priority review in epithelioid sarcoma, and more
-
8:45
fda approvals in gvhd, crc, and aml, a priority review in mcl, and more
-
10:42
fda approvals of a biosimilar and dtc genetic test, breakthrough designation in mzl, and more
-
10:00
fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
9:45
fda approval of a biosimilar, promising data in myeloma and gbm, and more
-
7:11
review on 2016 fda approvals, halt on aml trials, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
1:55
dr. hurvitz on the fda approval process for biosimilars
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
9:07
fda approvals in breast cancer and bladder cancer and phase iii data with larotrectinib
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
Clip.africa.com - Privacy-policy